Table 1

Diagnostic performances of GPR, APRI and Fib-4 in The Gambia using Fibroscan as a reference standard (n=721)*

F0–1 vs F2–4F0–2 vs F3–4F0–3 vs F4
GPR
 AUROC (95% CI)0.86 (0.82 to 0.90)0.86 (0.83 to 0.90)0.91 (0.87 to 0.96)
 Cut-off values†0.320.320.56
 Sensitivity/specificity (%)77/7578/7576/93
 Correctly classified (%)757591
 PPV/NPV (%)34/9532/9652/97
 Positive/negative LR3.1/0.33.0/0.310.6/0.3
APRI
 AUROC (95% CI)0.78 (0.73 to 0.84)0.80 (0.74 to 0.85)0.87 (0.80 to 0.93)
 Cut-off values‡0.51.5 1.02.0
 Sensitivity/specificity (%)70/7241/99 70/9655/99
 Correctly classified (%)7290 9395
 PPV/NPV (%)30/9383/91 62/9782/96
 Positive/negative LR2.5/0.428.3/0.6 16.3/0.344.7/0.5
 Indeterminate results (%)27 4
Fib-4
 AUROC (95% CI)0.75 (0.69 to 0.81)0.75 (0.69 to 0.81)0.85 (0.79 to 0.91)
 Cut-off values§ 1.453.25 
 Sensitivity/specificity (%) 67/7242/96 
 Correctly classified (%) 7189 
 PPV/NPV (%) 27/9363/91 
 Positive/negative LR 2.4/0.510.9/0.6 
 Indeterminate results (%) 25 
Comparison of AUROC
 GPR and APRIp=0.0004p=0.0003p=0.005
 GPR and Fib-4p<0.0001p<0.0001p=0.003
 APRI and Fib-4p=0.1p=0.03p=0.4
  • *The cut-off values for GGT were 58 and those for AST were 46 in men and 25 in women.

  • †Predetermined cut-off values of GPR were used.

  • ‡Predetermined cut-off values of APRI were used (0.5 and 1.5 to distinguish significant fibrosis, and 1.0 and 2.0 to distinguish cirrhosis).

  • §Predetermined cut-off values of Fib-4 were used (1.45 and 3.25 to distinguish extensive fibrosis).

  • APRI, aspartate transaminase-to-platelet ratio index; AST, aspartate transaminase; AUROC, area under the receiver operating characteristic curve; GPR, gamma-glutamyl transpeptidase to platelet ratio; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.